GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arbutus Biopharma Corp (STU:I9DN) » Definitions » Sale Of Investment

Arbutus Biopharma (STU:I9DN) Sale Of Investment : €87.90 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Arbutus Biopharma Sale Of Investment?

Arbutus Biopharma's sale of investment for the three months ended in Mar. 2024 was €0.00 Mil. It means Arbutus Biopharma gained €0.00 Mil from selling investments. Arbutus Biopharma's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €87.90 Mil.

Compared with last quarter (€42.41 Mil in Dec. 2023 ), Arbutus Biopharma gained less money from selling investments in Mar. 2024 (€0.00 Mil).


Arbutus Biopharma Sale Of Investment Historical Data

The historical data trend for Arbutus Biopharma's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arbutus Biopharma Sale Of Investment Chart

Arbutus Biopharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.91 60.33 62.26 52.86 121.29

Arbutus Biopharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.56 29.08 16.42 42.41 -

Arbutus Biopharma Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €87.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arbutus Biopharma Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Arbutus Biopharma's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Arbutus Biopharma (STU:I9DN) Business Description

Traded in Other Exchanges
Address
701 Veterans Circle, Warminster, PA, USA, 18974
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

Arbutus Biopharma (STU:I9DN) Headlines

No Headlines